Surprises From Trump’s First Week: mRNA Vaccine Investment, Abolishing Nuclear Weapons
Plus, early rising and money-manager outperformance
For all the extensive press coverage of President Trump’s first week back in office, at least two surprises have gotten less attention than they probably warrant.
Keep reading with a 7-day free trial
Subscribe to The Editors to keep reading this post and get 7 days of free access to the full post archives.